Rarebase, a privately held public benefit corporation pioneering a new approach to biotech, is the first public benefit corporation, focused on rare disease therapeutics, to enroll in the "Our Lives Matter" DEI Initiative, a community-developed diversity, equity and inclusion (DEI) research and educational initiative.

Successfully enrolling the minimum of five required participants, Rarebase's participation in the "Our Lives Matter" DEI unLearning program is a testament to their dedication to partnering with patient organizations on translational therapeutic discovery and development.

In addition to the active enrollment into the "Our Lives Matter" DEI unLearning program, the team at Rarebase has also enrolled into the "Our Lives Matter" Certification program. Upon completion of the certification program, will be eligible to receive the "Our Lives Matter" DEI Certified digital badge.

  • LinkedIn - White Circle

The Rare Advocacy Movement (RAM) is a novel rare disease community-based advocacy network designed to address the issues that affect the real world people of the rare disease community.  RAM is the only community-based Center of Insight and Collaboration Zone offering rare disease stakeholders authentic, comprehensive real world insights, from the source. Each RAM member has made a public vow to always act in the best interest of the rare disease community by abiding by the Code of Conduct for Membership. Those who violate the Code of Conduct for Membership risk removal from the RAM membership and access to the global network via majority vote.